Skip to main content
SpringerLink
Log in

AIDS Patients in the Intensive Care Unit

  • Chapter
Infection Control in the Intensive Care Unit

Part of the book series: Topics in Anaesthesia and Critical Care ((TIACC))

  • 955 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gayle HD, Hill GL (2001) Global impact of human immunodeficiency virus and AIDS. Clin Microbiol Rev 14:327–335

    Article  PubMed  CAS  Google Scholar 

  2. Curtis JR, Bennett CL, Horner RD, Rubenfeld GD, DeHovitz JA, Weinstein RA (1998) Variations in intensive care unit utilization for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia: importance of hospital characteristics and geographic location. Crit Care Med 26:668–675

    Article  PubMed  CAS  Google Scholar 

  3. Casalino E, Mendoza-Sassi G, Wolff M, Bedos JP, Gaudebout C, Regnier B, Vachon F (1998) Predictors of short-and long-term survival in HIV-infected patients admitted to the ICU. Chest 113:421–429

    PubMed  CAS  Google Scholar 

  4. Nickas G, Wachter RM (2000) Outcomes of intensive care for patients with human immunodeficiency virus infection. Arch Intern Med 160:541–547

    Article  PubMed  CAS  Google Scholar 

  5. Afessa B, Green B (2000) Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU. The PIP (Pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study. Chest 118:138–145

    Article  PubMed  CAS  Google Scholar 

  6. Wachter RM, Luce JM, Turner J, Volberding P, Hopewell PC (1986) Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization. Am Rev Respir Dis 134:891–896

    PubMed  CAS  Google Scholar 

  7. Schein RM, Fischl MA, Pitchenik AE, Sprung CL (1986) ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med 14:1026–1027

    Article  PubMed  CAS  Google Scholar 

  8. Alves C, Nicolas JM, Miro JM, Torres A, Agusti C, Gonzalez J, Rano A, Benito N, Moreno A, Garcia F, Milla J, Gatell JM (2001) Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients. Eur Respir J 17:87–93

    Article  PubMed  CAS  Google Scholar 

  9. Skiest DJ (2002) Focal neurological disease in patients with acquired immunodeficiency syndrome. Clin Infect Dis 34:103–115

    Article  PubMed  Google Scholar 

  10. Thyrault M, Gachot B, Chastang C, Souweine B, Timsit JF, Bedos JP, Regnier B, Wolff M (1997) Septic shock in patients with the acquired immunodeficiency syndrome. Intensive Care Med 23:1018–1023

    Article  PubMed  CAS  Google Scholar 

  11. Rosenberg AL, Seneff MG, Atiyeh L, Wagner R, Bojanowski L, Zimmerman JE (2001) The importance of bacterial sepsis in intensive care unit patients with acquired immunodeficiency syndrome: implications for future care in the age of increasing antiretroviral resistance. Crit Care Med 29:548–556

    Article  PubMed  CAS  Google Scholar 

  12. Rerkpattanapipat P, Wongpraparut N, Jacobs LE, Kotler MN (2000) Cardiac manifestations of acquired immunodeficiency syndrome. Arch Intern Med 160:602–608

    Article  PubMed  CAS  Google Scholar 

  13. Choperena G, Arcega I, Marco P, Alberdi F, Azaldegui F, Alberola I, von Wichman MA (2001) One-year survival of HIV-positive patients admitted to the ICU before the era of combined antiretroviral therapy. Medicina Intensiva 25:263–268

    Google Scholar 

  14. Hogan CM, Hammer SM (2001) Host determinants in HIV infection and disease. 1. Cellular and humoral immune responses. Ann Intern Med 134:761–776

    PubMed  CAS  Google Scholar 

  15. McMichael AJ, Rowland-Jones SL (2001) Cellular immune responses to HIV. Nature 410:980–987

    Article  PubMed  CAS  Google Scholar 

  16. Hogan CM, Hammer SM (2001) Host determinants in HIV infection and disease. 2. Genetic factors and implications for antiretroviral therapeutics. Ann Intern Med 134:978–996

    PubMed  CAS  Google Scholar 

  17. McCune JM (2001) The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410:974–979

    Article  PubMed  CAS  Google Scholar 

  18. Tranchat C, van de Perre P, Simonon-Sorel A, Karita E, Benchaib M, Lepage P, Desgranges C, Boyer V, Trepo C (1999) Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988–1994. J Infect 39:213–220

    Article  PubMed  CAS  Google Scholar 

  19. Lathey JL, Pratt RD, Spector SA (1997) Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1. J Infect Dis 175:231–232

    PubMed  CAS  Google Scholar 

  20. Parren PW, Moore JP, Burton DR, Sattentau QJ (1999) The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. AIDS 13[Suppl A]:S137–S162

    PubMed  CAS  Google Scholar 

  21. Poignard P, Sabbe R, Picchio GR, Wang M, Gulizia RJ, Katinger H, Parren PW, Mosier DE, Burton DR (1999) Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity 10:431–438

    Article  PubMed  CAS  Google Scholar 

  22. Weller IV, Williams IG (2001) ABC of AIDS. Antiretroviral drugs. BMJ 322:1410–1412

    Article  PubMed  CAS  Google Scholar 

  23. Tashima KT, Flanigan TP (2000) Antiretroviral therapy in the year 2000. Infect Dis Clin North Am 14:827–849

    Article  PubMed  CAS  Google Scholar 

  24. Raboud JM, Montaner JS, Conway B, Rae S, Reiss P, Vella S, Cooper D, Lange J, Harris M, Wainberg MA, Robinson P, Myers M, Hall D (1998) Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy. AIDS 12:1619–1624

    Article  PubMed  CAS  Google Scholar 

  25. Vella S, Palmisano L (2000) Antiretroviral therapy: state of the HAART. Antiviral Res 45:1–7

    Article  PubMed  CAS  Google Scholar 

  26. Sax PE (2001) Opportunistic infections in HIV disease: down but not out. Infect Dis Clin North Am 15:433–455

    Article  PubMed  CAS  Google Scholar 

  27. DeSimone JA, Pomerantz RJ, Babinchak TJ (2000) Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 133:447–454

    Google Scholar 

  28. Podzamczer D, Ramon AJ, Mallolas J, Maria PJ, Pulido F (2001) Treatment of opportunistic infections among adult and adolescent patients infected with the human immunodeficiency virus in the era of highly active anti-retroviral therapy. Enferm Infecc Microbiol Clin 19:376–392

    PubMed  CAS  Google Scholar 

  29. Barry SM, Johnson MA (2001) Pneumocystis carinii pneumonia: a review of current issues in diagnosis and management. HIV Med 2:123–132

    Article  PubMed  CAS  Google Scholar 

  30. Scully RE, Mark EJ, McNeely WF, Ebeling SH, Phillips LD (1997) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-1997. A 74-year-old man with progressive cough, dyspnea, and pleural thickening. N Engl J Med 336:1895–1903

    Article  PubMed  CAS  Google Scholar 

  31. Santamauro JT, Stover DE (1997) Pneumocystis carinii pneumonia. Med Clin North Am 81:299–318

    Article  PubMed  CAS  Google Scholar 

  32. Gonzalez-Garcia J, Rubio GR, Antela LA, Garcia AF (1998) Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment. Enferm Infecc Microbiol Clin 16[Suppl] 1:36–44

    PubMed  Google Scholar 

  33. Fishman JA (1998) Treatment of infection due to Pneumocystis carinii. Antimicrob Agents Chemother 42:1309–1314

    PubMed  CAS  Google Scholar 

  34. The National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia (1990) Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 323:1500–1504

    Article  Google Scholar 

  35. Mansharamani NG, Garland R, Delaney D, Koziel H (2000) Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 118:704–711

    Article  PubMed  CAS  Google Scholar 

  36. Bedos JP, Dumoulin JL, Gachot B, Veber B, Wolff M, Regnier B, Chevret S (1999) Pneumocystis carinii pneumonia requiring intensive care management: survival and prognostic study in 110 patients with human immunodeficiency virus. Crit Care Med 27:1109–1115

    Article  PubMed  CAS  Google Scholar 

  37. US Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA) (1999) 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Recomm Rep 48:1–6

    Google Scholar 

  38. Berenguer J, Blazquez R, Ocana I, Lozano F (1998) Infections by Candida and cryptococci. Enferm Infecc Microbiol Clin 16 [Suppl] 1:29–35

    Google Scholar 

  39. Graybill JR, Sobel J, Saag M, van der Horst CM, Powderly W, Cloud G, Riser L, Hamill R, Dismukes W (2000) Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 30:47–54

    Article  PubMed  CAS  Google Scholar 

  40. van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, Johnson PC, Tuazon CU, Kerkering T, Moskovitz BL, Powderly WG, Dismukes WE (1997) Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med 337:15–21

    Article  PubMed  Google Scholar 

  41. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE (2000) Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 30:710–718

    Article  PubMed  CAS  Google Scholar 

  42. Ribera PE, Lopez AJ, Perez Elias MJ, Podzamczer PD (1998) Cerebral toxoplasmosis. Enferm Infecc Microbiol Clin 16[Suppl 1]:45–51

    Google Scholar 

  43. Skiest DJ (2002) Focal neurological disease in patients with acquired immunodeficiency syndrome. Clin Infect Dis 34:103–115

    Article  PubMed  Google Scholar 

  44. Ammassari A, Cingolani A, Pezzotti P, De Luca DA, Murri R, Giancola ML, Larocca LM, Antinori A (2000) AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 55:1194–2000

    PubMed  CAS  Google Scholar 

  45. Ciricillo SF, Rosenblum ML (1990) Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J Neurosurg 73:720–724

    Article  PubMed  CAS  Google Scholar 

  46. Skiest DJ, Erdman W, Chang WE, Oz OK, Ware A, Fleckenstein J (2000) SPECT thallium-201 combined with Toxoplasma serology for the presumptive diagnosis of focal central nervous system mass lesions in patients with AIDS. J Infect 40:274–281

    Article  PubMed  CAS  Google Scholar 

  47. Santin M, Torres-Tortosa M, Redondo A, Sola J (1998) Other infections (Streptococcus pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa, Salmonella spp., Campylobacter spp., Nocardia asteroides, Rhodococcus equi and Bartonella spp.). Enferm Infecc Microbiol Clin 16[Suppl] 1:61–66

    PubMed  Google Scholar 

  48. Kovacs A, Leaf HL, Simberkoff MS (1997) Bacterial infections. Med Clin North Am 81:319–343

    Article  PubMed  CAS  Google Scholar 

  49. Small PM, Fujiwara PI (2001) Management of tuberculosis in the United States. N Engl J Med 345:189–200

    Article  PubMed  CAS  Google Scholar 

  50. Burman WJ, Jones BE (2001) Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. Am J Respir Crit Care Med 164:7–12

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Intensive Care Unit, Juan Canalejo Hospital, Coruña, Spain

    L. Alvarez-Rocha, P. Rascado-Sedes & J. Pastor-Benavent

  2. Intensive Care Unit, Arnau de Vilanova Hospital, Lleida, Spain

    F. Barcenilla-Gaite

Authors
  1. L. Alvarez-Rocha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Rascado-Sedes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Pastor-Benavent
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Barcenilla-Gaite
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medical Microbiology, University of Liverpool Alder Hey Children’s Hospital, NHS Trust, Liverpool, UK

    H. K. F. van Saene M.D.

  2. Department of Critical Care Medicine, University Hospital of Getafe, Madrid, Spain

    M. A. De La Cal M.D.

  3. Emergency Department and Unit of Anesthesia and Intensive Care, Presidio Ospedaliero of Gorizia, Gorizia, Italy

    L. Silvestri M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Italia

About this chapter

Cite this chapter

Alvarez-Rocha, L., Rascado-Sedes, P., Pastor-Benavent, J., Barcenilla-Gaite, F. (2005). AIDS Patients in the Intensive Care Unit. In: van Saene, H.K.F., De La Cal, M.A., Silvestri, L. (eds) Infection Control in the Intensive Care Unit. Topics in Anaesthesia and Critical Care. Springer, Milano . https://doi.org/10.1007/88-470-0361-X_22

Download citation

  • DOI: https://doi.org/10.1007/88-470-0361-X_22

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0185-5

  • Online ISBN: 978-88-470-0361-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation